Publications
- Posttreatment positivity of BCR::ABL1 in acute lymphoblastic leukemia: Should we keep track?2023 | Second Faculty of Medicine
- Measurable residual disease analysis in paediatric acute lymphoblastic leukaemia patients with ABL-class fusions2022 | Second Faculty of Medicine
- Impact of BCR::ABL1 transcript type on RT-qPCR amplification performance and molecular response to therapy2022 | Second Faculty of Medicine
- Minimal residual disease in BCR::ABL1-positive acute lymphoblastic leukemia: different significance in typical ALL and in CML-like disease2022 | Second Faculty of Medicine
- Analysis of chronic myeloid leukaemia during deep molecular response by genomic PCR: a traffic light stratification model with impact on treatment-free remission2020 | First Faculty of Medicine, Second Faculty of Medicine
- Metabolic profile of leukemia cells influences treatment efficacy of L-asparaginase2020 | Second Faculty of Medicine
- ERG deletions in childhood acute lymphoblastic leukemia with DUX4 rearrangements are mostly polyclonal, prognostically relevant and their detection rate strongly depends on screening method sensitivity2019 | Second Faculty of Medicine
- Monitoring of childhood ALL using BCR-ABL1 genomic breakpoints identifies a subgroup with CML-like biology2017 | Second Faculty of Medicine
- Slower early response to treatment and distinct expression profile of childhood high hyperdiploid acute lymphoblastic leukaemia with DNA index < 1.162016 | Second Faculty of Medicine
- Intragenic ERG Deletions Do Not Explain the Biology of ERG-Related Acute Lymphoblastic Leukemia2016 | Second Faculty of Medicine
Loading network view...